对于自身免疫性肝炎的儿科共识
Elizabeth Hernández-Chávez1, Judith Flores-Calderón2, Flora Zárate-Mondragón3
1Departamento de Gastroenterología Pediátrica, Unidad Médica de Alta Especialidad, Hospital de Pediatría, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jal.
Boletin medico del Hospital Infantil de Mexico
|December 16, 2025
概括
这一共识为儿童自身免疫性肝炎的诊断和治疗提供了最新的指导方针. 它涉及这种罕见的儿科肝病的早期管理,并发症和治疗策略.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
背景情况:
- 自身免疫性肝炎是一种罕见但在儿科患者中具有挑战性的肝病.
- 准确的诊断和及时的治疗对于预防疾病进展和并发症至关重要.
研究的目的:
- 为医生提供最新的,基于证据的信息,用于诊断和治疗儿科患者的自身免疫性肝炎.
- 建立关于管理儿科自身免疫性肝炎的共识建议.
主要方法:
- 儿科胃肠病学家和移植外科医生进行了一项文献综述.
- 采用了德尔菲方法,包括虚拟会议进行分析和对陈述进行投票.
- 在诊断,管理和治疗方面批准了46份共识陈述.
主要成果:
- 该共识为儿童自身免疫性肝炎的诊断提供了建议.
- 它概述了早期管理的策略,以预防疾病进展和肝硬化并发症.
- 提供关于管理治疗失败,检测不良事件,替代疗法和肝移植指示的指导.
结论:
- 提出了针对儿童自身免疫性肝炎的诊断和治疗的最新建议.
- 这种共识旨在改善这种罕见的儿科肝病的管理.
- 建议中包括了特定的儿科剂量考虑因素.
相关概念视频
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
174
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
174
01:29Autoimmune Disorders
1.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.4K
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
229
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
229
01:29Chronic Pancreatitis II: Collaborative Care
286
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
286
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
194
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
194